TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12458361

Group type: EXPERIMENTAL
Intervention: Al-adjuvanted low-dose formulations (1.9 micro g HA/strain per dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Al-adjuvanted low-dose formulations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard split virus vaccine (Fluarix)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Al-adjuvanted whole virus formulations with reduced antigen content
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Al-adjuvanted whole virus vaccines with low HA content
Number of subjects: 0
Study: 9593249

Group type: COMPARATOR
Intervention: Control (n = 20)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Mechanical (n = 21)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Mechanical plus oral metronidazole (n = 20)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Polyethylene glycol preparation (n = 21)
Number of subjects: 82
Study: 8553302

Group type: EXPERIMENTAL
Intervention: Beclomethasone (BDP) 800 micrograms/day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Beclomethasone (BDP) 2000 micrograms/day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Beclomethasone (BDP) 1400 micrograms/day
Number of subjects: 12

Group type: COMPARATOR
Intervention: Inhaled placebo
Number of subjects: 12
Study: 2242972

Group type: EXPERIMENTAL
Intervention: Defibrotide (400 mg b.i.d., intramuscular injection, starting one day before surgery and continuing for seven postoperative days)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Calcium heparin (5000 IU t.i.d., subcutaneous injection, starting two hours before surgery and continuing for seven days)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Defibrotide
Number of subjects: 160

Group type: COMPARATOR
Intervention: Calcium heparin
Number of subjects: 160
Study: 76165

Group type: EXPERIMENTAL
Intervention: Cimetidine therapy for 6 weeks
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (no cimetidine)
Number of subjects: 8
Study: 11706341

Group type: EXPERIMENTAL
Intervention: Tourniquet-controlled
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no tourniquet)
Number of subjects: 0
Study: 31254472

Group type: EXPERIMENTAL
Intervention: Cangrelor
Number of subjects: 10854
Study: 29046957

Group type: COMPARATOR
Intervention: Heller myotomy
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Heller myotomy with Dor fundoplication
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 41
Study: 26669989

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: COMPARATOR
Intervention: Subjective pain ratings
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 24
Study: 25131479

Group type: EXPERIMENTAL
Intervention: Intensive lipid modulation (atorvastatin 40 mg every night before surgery, 80 mg 12 h before surgery, 40 mg 2 h before surgery, and 40 mg every night after surgery)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional group (atorvastatin 20 mg every night before surgery and after surgery)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intensive lipid modulation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 60
Study: 22268852

Group type: EXPERIMENTAL
Intervention: Aspirin 81 mg/day
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Clopidogrel 75 mg/day
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg/day
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Aspirin 81 mg/day plus Clopidogrel 75 mg/day
Number of subjects: 51

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 51
Study: 20528839

Group type: EXPERIMENTAL
Intervention: Interpleural analgesia with a 20-ml loading dose of levo bupivacaine 0.5% followed by a continuous infusion of levobupivacaine 0.125%
Number of subjects: 50

Group type: COMPARATOR
Intervention: Multimodal analgesia with intravenous morphine patient‐controlled analgesia
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Interpleural analgesia
Number of subjects: 50
Study: 17114188

Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo followed by infliximab
Number of subjects: 200
Study: 15890355

Group type: EXPERIMENTAL
Intervention: Bovine serum albumin (BSA) as an intrathoracic surgical sealant during pneumonectomy
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 143
Study: 12553485

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) + Lamivudine (3TC)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Abacavir (ABC) + Lamivudine (3TC)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Nelfinavir (NFV)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: 3TC
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) + Abacavir (ABC)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: 3TC + ABC
Number of subjects: 113
Study: 10392107

Group type: EXPERIMENTAL
Intervention: Community-based intervention (education about nutrition and parenting skills)
Number of subjects: 39
Study: 7664901

Group type: EXPERIMENTAL
Intervention: Pre-operative hyperthermo-chemo-radiotherapy (HCR)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Pre-operative radiation therapy alone (R)
Number of subjects: 51
Study: 2701039

Group type: EXPERIMENTAL
Intervention: Propranolol 120‐480 mg daily, mean dose 280 mg for 6‐9 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pindolol 10‐35 mg daily, mean dose 22 mg for 6‐9 weeks
Number of subjects: 40
Study: 67468

Group type: EXPERIMENTAL
Intervention: Intrathecal administration of 200 units of antitetanus serum (A.T.S.) (horse)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Control series (no intrathecal A.T.S.)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Intrathecal administration of 200 units A.T.S. (horse)
Number of subjects: 322
Study: 31968307

Group type: EXPERIMENTAL
Intervention: Mental Fatigue (MF) - 60-min incongruent Stroop task
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control - 60 min of an emotionally neutral documentary
Number of subjects: 19
Study: 30113523

Group type: EXPERIMENTAL
Intervention: ET-BFR (n = 10, 4 d·wk, 30-min cycling at 40% of V˙O2max)
Number of subjects: 30

Group type: COMPARATOR
Intervention: RT (n = 10, 4 d·wk, 4 sets of 10 repetitions leg press at 70% of one repetition maximum with 60 s rest)
Number of subjects: 30

Group type: COMPARATOR
Intervention: ET (n = 10, 4 d·wk, 30-min cycling at 70% of V˙O2max)
Number of subjects: 30
Study: 28082016

Group type: EXPERIMENTAL
Intervention: Tablet computer training intervention (N=22 participants attended a weekly 2-hour class for 10 weeks)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (N=21 participants)
Number of subjects: 48
Study: 25585164

Group type: EXPERIMENTAL
Intervention: Minimally processed wheat bran
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Wheat aleurone
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Aleurone bread
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 27
Study: 23514124

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Light therapy (LT)
Number of subjects: 160
Study: 21503000

Group type: EXPERIMENTAL
Intervention: Celecoxib 400 mg once daily (933 subjects)
Number of subjects: 1561

Group type: COMPARATOR
Intervention: Placebo (628 subjects)
Number of subjects: 1561
Study: 18512045

Group type: EXPERIMENTAL
Intervention: Neural triggering and cycling-off
Number of subjects: 7

Group type: COMPARATOR
Intervention: Pneumatic triggering and cycling-off
Number of subjects: 7
Study: 16585287

Group type: EXPERIMENTAL
Intervention: Cow's milk-elimination diet (n = 19)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Continue previous diet (n = 21)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 40
Study: 12815302

Group type: EXPERIMENTAL
Intervention: Selective endothelin receptor-A antagonist BQ-123 administered by the intracoronary route
Number of subjects: 0
Study: 10577557

Group type: EXPERIMENTAL
Intervention: Dopamine 2 microg/kg/min plus 120 ml/day of 0.9% saline
Number of subjects: 66

Group type: COMPARATOR
Intervention: Saline alone
Number of subjects: 66
Study: 8712126

Group type: EXPERIMENTAL
Intervention: Acute catheterization, angioplasty, thrombolysis, or coronary bypass surgery (men)
Number of subjects: 1097

Group type: COMPARATOR
Intervention: Hospital mortality (women)
Number of subjects: 1097

Group type: COMPARATOR
Intervention: Older age, early evidence of hemodynamic instability, intraventricular conduction abnormality on ECG (predictors for hospital mortality)
Number of subjects: 1097
Study: 2022160

Group type: EXPERIMENTAL
Intervention: Water-soluble diclofenac
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Delayed-release diclofenac
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 6756632

Group type: EXPERIMENTAL
Intervention: Cefotaxime perioperatively only
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Cefotaxime perioperatively plus postoperative doses every six hours for 24 hours
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Cefazolin perioperatively plus postoperative doses every six hours for 24 hours
Number of subjects: 360
Study: 31383609

Group type: EXPERIMENTAL
Intervention: Nanosilver foam (SF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Collagen (C)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Silver nanoparticle gel (SG)
Number of subjects: 20
Study: 28515079

Group type: EXPERIMENTAL
Intervention: Acetaminophen (APAP) 1,000 mg/6 h for 24 h before and immediately following RE
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 8
Study: 26262642

Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplementation (MMN)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Iron supplementation (Fe)
Number of subjects: 184
Study: 23046177

Group type: EXPERIMENTAL
Intervention: Health-oriented reality program with healthy food ads
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Health-oriented reality program with unhealthy food ads
Number of subjects: 253

Group type: COMPARATOR
Intervention: Non-health-oriented reality program
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Health-themed sitcom with healthy food ads
Number of subjects: 253

Group type: COMPARATOR
Intervention: Health-themed sitcom with unhealthy food ads
Number of subjects: 253
Study: 21624416

Group type: EXPERIMENTAL
Intervention: VAX102 (STF2.4xM2e) at doses of 0.03 μg, 0.1 μg, 0.3 μg, and 1.0 μg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 19149344

Group type: EXPERIMENTAL
Intervention: Intranasally administered oxymetazoline
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intranasally administered surfactant
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intranasally administered acetylcysteine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Orally administered pseudoephedrine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline-placebo
Number of subjects: 8
Study: 16864822

Group type: EXPERIMENTAL
Intervention: Diaphragmatic response to transcranial magnetic stimulation (TMS)
Number of subjects: 27
Study: 12618330

Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: XRCC1 codon 399 genotype
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 0
Study: 10828770

Group type: EXPERIMENTAL
Intervention: Prepayment systems
Number of subjects: 860

Group type: COMPARATOR
Intervention: No prepayment system
Number of subjects: 860
Study: 9596418

Group type: EXPERIMENTAL
Intervention: Intravenous boluses of isosorbide dinitrate
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sublingual sprays of isosorbide dinitrate
Number of subjects: 72
Study: 8172092

Group type: EXPERIMENTAL
Intervention: 40%‐fat diet with fish or fish oil
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 30%‐fat diet
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 30%‐fat diet with fish
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: One daily fish meal
Number of subjects: 7
Study: 3151984

Group type: EXPERIMENTAL
Intervention: Lithium treatment (Group I: 0.08-0.33 mmol/l, mean: 0.23 mmol/l; Group II: 0.40-0.84 mmol/l, mean: 0.555 mmol/l)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Lithium treatment (Group II)
Number of subjects: 44
Study: 28714738

Group type: EXPERIMENTAL
Intervention: Experience Sampling Method (ESM) intervention 'Partner in Sight'
Number of subjects: 90
Study: 27121123

Group type: EXPERIMENTAL
Intervention: Ergonomics training only
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Safety voice training only
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Combined ergonomics and safety voice training
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group with no additional training intervention
Number of subjects: 96
Study: 25767805

Group type: EXPERIMENTAL
Intervention: P. lanceolata mouth rinse
Number of subjects: 0
Study: 23933905

Group type: EXPERIMENTAL
Intervention: Metadoxine extended release (ER) 1400 mg/day for 6 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 20642206

Group type: EXPERIMENTAL
Intervention: mometasone furoate nasal spray (200 microg)
Number of subjects: 30
Study: 18560141

Group type: EXPERIMENTAL
Intervention: Mirror therapy (eye open)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Mirror therapy (eye closed)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Mirror therapy (right hand clenching with eye open)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Mirror therapy (patient 2)
Number of subjects: 8
Study: 16369892

Group type: COMPARATOR
Intervention: HRT (conjugated estrogen at a dose of 0.31 mg/day + medroxyprogesterone acetate 2.5 mg/day)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: HRT + alfacalcidol (1.0 microg/day)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Comparison of HRT and HRT + alfacalcidol
Number of subjects: 76
Study: 12466161

Group type: EXPERIMENTAL
Intervention: Mitomycin-C (MMC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-site surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phacoemulsification
Number of subjects: 0

Group type: COMPARATOR
Intervention: Staged procedures
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alternative glaucoma procedures
Number of subjects: 0
Study: 15605452

Group type: EXPERIMENTAL
Intervention: Avorax
Number of subjects: 12

Group type: COMPARATOR
Intervention: Zovirax
Number of subjects: 12
Study: 7882787

Group type: EXPERIMENTAL
Intervention: High pressure, closed suction pelvic drain for seven days
Number of subjects: 100

Group type: COMPARATOR
Intervention: No drain
Number of subjects: 100
Study: 2179362

Group type: EXPERIMENTAL
Intervention: Low dose quinidine-mexiletine combination therapy
Number of subjects: 15

Group type: COMPARATOR
Intervention: Quinidine monotherapy
Number of subjects: 15
Study: 366538

Group type: EXPERIMENTAL
Intervention: Desmopressin (DDAVP) given by nose drops
Number of subjects: 22

Group type: COMPARATOR
Intervention: Saline alone as placebo
Number of subjects: 22
Study: 6805621

Group type: EXPERIMENTAL
Intervention: Conventional hydralazine 100 mg twice daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Conventional hydralazine 200 mg once daily
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Slow-release hydralazine 200 mg once daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30589722

Group type: EXPERIMENTAL
Intervention: FAST verbal encouragement
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: BOTH verbal encouragement
Number of subjects: 23

Group type: COMPARATOR
Intervention: HARD verbal encouragement
Number of subjects: 23

Group type: COMPARATOR
Intervention: NO CUE verbal encouragement
Number of subjects: 23
Study: 29379943

Group type: EXPERIMENTAL
Intervention: 200 mg of mixed tocotrienols twice daily for 12 months
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo for 12 months
Number of subjects: 300
Study: 26839066

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 18201

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 18201

Group type: EXPERIMENTAL
Intervention: IL‐6
Number of subjects: 18201

Group type: EXPERIMENTAL
Intervention: CRP
Number of subjects: 18201

Group type: EXPERIMENTAL
Intervention: IL‐6 and CRP
Number of subjects: 18201
Study: 24161142

Group type: EXPERIMENTAL
Intervention: CABG with at least 2 arterial grafts
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Clopidogrel at discharge
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Statins at discharge
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Left ventricular ejection fraction <30%
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Age <40 years
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Estimated glomerular filtration rate <60 ml/min/1.73 m(2)
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Non‐ST‐elevation myocardial infarction/ST‐elevation myocardial infarction
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Emergency procedure
Number of subjects: 592
Study: 21779817

Group type: EXPERIMENTAL
Intervention: Centralized coordinator intervention
Number of subjects: 267

Group type: COMPARATOR
Intervention: Simple fall prevention advice (control)
Number of subjects: 267
Study: 19167122

Group type: EXPERIMENTAL
Intervention: Short-term chemotherapy (cisplatin 70 mg/m² for 1 day and 5FU 700 mg/m² for 5 days) with radiotherapy (RT) of 60Gy/30 fractions/7 weeks.
Number of subjects: 91

Group type: COMPARATOR
Intervention: Protracted chemotherapy (cisplatin 7 mg/m² for 10 days and 5FU 250 mg/m² for 14 days) with radiotherapy (RT) of 60Gy/30 fractions/7 weeks.
Number of subjects: 91
Study: 17496643

Group type: EXPERIMENTAL
Intervention: Current steering applied to electrode pairs (2 and 3, 8 and 9, 13 and 14)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Current steering
Number of subjects: 57
Study: 15688191

Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg/day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intranasal salmon calcitonin (sCT) 200 IU/day
Number of subjects: 50
Study: 11888741

Group type: EXPERIMENTAL
Intervention: eloHAES
Number of subjects: 22

Group type: COMPARATOR
Intervention: gelofusine
Number of subjects: 22
Study: 10213112

Group type: EXPERIMENTAL
Intervention: Endoscopic injection sclerotherapy with ligation (EISL)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Endoscopic injection sclerotherapy (EIS)
Number of subjects: 28
Study: 8869024

Group type: EXPERIMENTAL
Intervention: c7E3
Number of subjects: 0
Study: 2120987

Group type: EXPERIMENTAL
Intervention: Gadopentetate dimeglumine (0.2 ml/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (normal saline, 0.2 ml/kg)
Number of subjects: 12
Study: 917259

Group type: EXPERIMENTAL
Intervention: Intravenous heroin administration
Number of subjects: 2

Group type: COMPARATOR
Intervention: Saline placebo administration
Number of subjects: 2
Study: 31122088

Group type: EXPERIMENTAL
Intervention: DSSFTN (Decision Support System for Total Nutrients)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard PN calculated by doctors
Number of subjects: 38
Study: 31386463

Group type: EXPERIMENTAL
Intervention: Direct Randomized Benchmarking (RB) protocol using random circuits over native gates seeded by an initial layer of Clifford-like randomization.
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Direct Randomized Benchmarking (RB) protocol
Number of subjects: 5

Group type: COMPARATOR
Intervention: Clifford Randomized Benchmarking (RB)
Number of subjects: 5
Study: 27722908

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cancer Recovery (MBCR)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Supportive Expressive Group Therapy (SET)
Number of subjects: 139
Study: 27406988

Group type: EXPERIMENTAL
Intervention: Y grafting configuration
Number of subjects: 304

Group type: COMPARATOR
Intervention: in situ configuration
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Both configurations
Number of subjects: 304
Study: 25335963

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) plus treatment as usual
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual alone
Number of subjects: 0
Study: 22075018

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.3%
Number of subjects: 76

Group type: COMPARATOR
Intervention: NaCl 0.9% (Placebo)
Number of subjects: 76
Study: 19356306

Group type: EXPERIMENTAL
Intervention: 400 mg of docosahexaenoic acid (DHA)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1000 mg of docosahexaenoic acid (DHA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 18693828

Group type: EXPERIMENTAL
Intervention: Health information technology intervention 1
Number of subjects: 17000

Group type: EXPERIMENTAL
Intervention: Health information technology intervention 2
Number of subjects: 17000

Group type: EXPERIMENTAL
Intervention: Health information technology intervention 3
Number of subjects: 17000
Study: 14691117

Group type: EXPERIMENTAL
Intervention: APF+FD
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: APF+PD
Number of subjects: 16

Group type: COMPARATOR
Intervention: FD
Number of subjects: 16

Group type: COMPARATOR
Intervention: PD
Number of subjects: 16
Study: 12486792

Group type: EXPERIMENTAL
Intervention: Fluconazole at 100-400 mg daily for the first 1-3 months post-liver transplantation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhaled liposomal preparations post-organ transplantation or preemptive use of itraconazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Molecular diagnostic techniques for identification and preemptive therapy
Number of subjects: 0
Study: 10340968

Group type: COMPARATOR
Intervention: Group 1 (attended for follow up)
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Group 2 (difficult to trace)
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Group 3 (very reluctant for assessment)
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Total cohort
Number of subjects: 558
Study: 8846750

Group type: EXPERIMENTAL
Intervention: Contractubex gel (10% onion extract, 50 U sodium heparin per g of gel, 1% allantoin)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Contractubex gel
Number of subjects: 65

Group type: COMPARATOR
Intervention: Untreated (control)
Number of subjects: 65